RA
Radiopharm Theranostics Limited (RADX)
NASDAQ·Healthcare·Biotechnology
$3.10
-1.75%
Mkt Cap $6.36M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+93.9%
Consensus $6.00 vs current $3.10
NASDAQ·Healthcare·Biotechnology
$3.10
-1.75%
Mkt Cap $6.36M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+93.9%
Consensus $6.00 vs current $3.10